NVAX logo

Novavax (NVAX) Operating Expenses

Annual Operating Expenses

$779.13 M
-$561.92 M-41.90%

December 31, 2023


Summary


Performance

NVAX Operating Expenses Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherNVAXexpensesmetrics:

Quarterly Operating Expenses

$157.91 M
-$50.33 M-24.17%

September 30, 2024


Summary


Performance

NVAX Quarterly Operating Expenses Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherNVAXexpensesmetrics:

Operating Expenses Formula

Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses

NVAX Operating Expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-41.9%+223.8%
3 y3 years+77.4%+60.4%
5 y5 years+274.2%+501.0%

NVAX Operating Expenses Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-58.6%at low-60.3%+223.8%
5 y5-year-58.6%+425.5%-75.9%+1597.6%
alltimeall time-58.6%>+9999.0%-75.9%+2456.9%

Novavax Operating Expenses History

DateAnnualQuarterly
Sep 2024
-
$157.91 M(-24.2%)
Jun 2024
-
$208.24 M(+16.0%)
Mar 2024
-
$179.48 M(-36.4%)
Dec 2023
$779.13 M(-41.9%)
$281.99 M(+478.2%)
Sep 2023
-
$48.77 M(-84.4%)
Jun 2023
-
$313.19 M(+15.0%)
Mar 2023
-
$272.25 M(-22.2%)
Dec 2022
$1.34 B(-28.8%)
$349.94 M(+9.0%)
Sep 2022
-
$320.90 M(-19.3%)
Jun 2022
-
$397.81 M(+4.6%)
Mar 2022
-
$380.17 M(+286.1%)
Dec 2021
$1.88 B(+329.1%)
$98.46 M(-79.7%)
Sep 2021
-
$485.99 M(-24.5%)
Jun 2021
-
$643.85 M(-1.8%)
Mar 2021
-
$655.86 M(+6950.8%)
Dec 2020
$439.11 M(+196.2%)
$9.30 M(-97.3%)
Sep 2020
-
$350.97 M(+567.7%)
Jun 2020
-
$52.56 M(+100.1%)
Mar 2020
-
$26.27 M(-30.0%)
Dec 2019
$148.26 M(-28.8%)
$37.52 M(+41.5%)
Sep 2019
-
$26.51 M(-33.8%)
Jun 2019
-
$40.02 M(-9.5%)
Mar 2019
-
$44.20 M(-16.0%)
Dec 2018
$208.21 M(+2.6%)
$52.64 M(+6.1%)
Sep 2018
-
$49.63 M(-5.9%)
Jun 2018
-
$52.77 M(-0.8%)
Mar 2018
-
$53.17 M(-8.6%)
Dec 2017
$202.89 M(-28.7%)
$58.20 M(+16.4%)
Sep 2017
-
$49.98 M(+3.7%)
Jun 2017
-
$48.20 M(+3.6%)
Mar 2017
-
$46.51 M(-21.8%)
Dec 2016
$284.47 M(+47.0%)
$59.44 M(-10.7%)
Sep 2016
-
$66.54 M(-15.8%)
Jun 2016
-
$79.00 M(-0.6%)
Mar 2016
-
$79.48 M(-6.2%)
Dec 2015
$193.49 M(+69.2%)
$84.75 M(+113.4%)
Sep 2015
-
$39.72 M(+14.1%)
Jun 2015
-
$34.82 M(+1.8%)
Mar 2015
-
$34.19 M(-32.3%)
Dec 2014
$114.35 M(+55.9%)
$50.54 M(+110.8%)
Sep 2014
-
$23.98 M(+14.1%)
Jun 2014
-
$21.01 M(+11.6%)
Mar 2014
-
$18.83 M(-34.2%)
Dec 2013
$73.35 M(+98.0%)
$28.62 M(+60.7%)
Sep 2013
-
$17.80 M(+20.3%)
Jun 2013
-
$14.80 M(+22.0%)
Mar 2013
-
$12.13 M(+0.1%)
Dec 2012
$37.05 M(+26.6%)
$12.11 M(+38.0%)
Sep 2012
-
$8.78 M(+11.9%)
Jun 2012
-
$7.84 M(-5.8%)
Mar 2012
-
$8.32 M(+21.3%)
Dec 2011
$29.26 M(-24.6%)
$6.86 M(+1.1%)
Sep 2011
-
$6.79 M(-11.8%)
Jun 2011
-
$7.69 M(-2.9%)
Mar 2011
-
$7.92 M(+11.8%)
Dec 2010
$38.84 M
$7.08 M(-33.9%)
Sep 2010
-
$10.71 M(+13.1%)
DateAnnualQuarterly
Jun 2010
-
$9.47 M(-18.1%)
Mar 2010
-
$11.56 M(-18.7%)
Dec 2009
$37.71 M(+6.4%)
$14.23 M(+68.1%)
Sep 2009
-
$8.46 M(+7.7%)
Jun 2009
-
$7.86 M(+9.8%)
Mar 2009
-
$7.16 M(-22.9%)
Dec 2008
$35.42 M(+12.2%)
$9.28 M(-6.5%)
Sep 2008
-
$9.92 M(+16.1%)
Jun 2008
-
$8.55 M(+11.3%)
Mar 2008
-
$7.68 M(+34.3%)
Dec 2007
$31.56 M(+39.6%)
$5.71 M(-39.7%)
Sep 2007
-
$9.48 M(+18.0%)
Jun 2007
-
$8.03 M(-2.7%)
Mar 2007
-
$8.25 M(+62.4%)
Dec 2006
$22.62 M(+144.5%)
$5.08 M(-11.2%)
Sep 2006
-
$5.72 M(-14.9%)
Jun 2006
-
$6.72 M(+40.2%)
Mar 2006
-
$4.79 M(-171.5%)
Dec 2005
$9.25 M(-68.4%)
-$6.70 M(-320.7%)
Sep 2005
-
$3.04 M(-44.9%)
Jun 2005
-
$5.51 M(-25.5%)
Mar 2005
-
$7.40 M(-30.1%)
Dec 2004
$29.23 M(+13.4%)
$10.59 M(+306.0%)
Sep 2004
-
$2.61 M(-70.5%)
Jun 2004
-
$8.84 M(+12.6%)
Mar 2004
-
$7.85 M(+22.0%)
Dec 2003
$25.78 M(-21.9%)
$6.43 M(-0.5%)
Sep 2003
-
$6.47 M(-0.8%)
Jun 2003
-
$6.52 M(+2.5%)
Mar 2003
-
$6.36 M(+8.5%)
Dec 2002
$33.00 M(+12.8%)
$5.86 M(-27.2%)
Sep 2002
-
$8.04 M(-10.3%)
Jun 2002
-
$8.97 M(-11.5%)
Mar 2002
-
$10.13 M(+26.0%)
Dec 2001
$29.27 M(+85.1%)
$8.04 M(+22.0%)
Sep 2001
-
$6.59 M(-23.1%)
Jun 2001
-
$8.57 M(+41.0%)
Mar 2001
-
$6.08 M(-1.6%)
Dec 2000
$15.81 M(+155.0%)
$6.18 M(+60.5%)
Sep 2000
-
$3.85 M(+9.4%)
Jun 2000
-
$3.52 M(+55.2%)
Mar 2000
-
$2.27 M(+19.3%)
Dec 1999
$6.20 M(0.0%)
$1.90 M(-9.5%)
Sep 1999
-
$2.10 M(+90.9%)
Jun 1999
-
$1.10 M(0.0%)
Mar 1999
-
$1.10 M(-45.0%)
Dec 1998
$6.20 M(+10.7%)
$2.00 M(+33.3%)
Sep 1998
-
$1.50 M(0.0%)
Jun 1998
-
$1.50 M(+25.0%)
Mar 1998
-
$1.20 M(-20.0%)
Dec 1997
$5.60 M(-5.1%)
$1.50 M(+7.1%)
Sep 1997
-
$1.40 M(0.0%)
Jun 1997
-
$1.40 M(+7.7%)
Mar 1997
-
$1.30 M(-31.6%)
Dec 1996
$5.90 M
$1.90 M(+58.3%)
Sep 1996
-
$1.20 M(-20.0%)
Jun 1996
-
$1.50 M(+15.4%)
Mar 1996
-
$1.30 M

FAQ

  • What is Novavax annual total operating expenses?
  • What is the all time high annual operating expenses for Novavax?
  • What is Novavax annual operating expenses year-on-year change?
  • What is Novavax quarterly total operating expenses?
  • What is the all time high quarterly operating expenses for Novavax?
  • What is Novavax quarterly operating expenses year-on-year change?

What is Novavax annual total operating expenses?

The current annual operating expenses of NVAX is $779.13 M

What is the all time high annual operating expenses for Novavax?

Novavax all-time high annual total operating expenses is $1.88 B

What is Novavax annual operating expenses year-on-year change?

Over the past year, NVAX annual total operating expenses has changed by -$561.92 M (-41.90%)

What is Novavax quarterly total operating expenses?

The current quarterly operating expenses of NVAX is $157.91 M

What is the all time high quarterly operating expenses for Novavax?

Novavax all-time high quarterly total operating expenses is $655.86 M

What is Novavax quarterly operating expenses year-on-year change?

Over the past year, NVAX quarterly total operating expenses has changed by +$109.14 M (+223.81%)